Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 131, Issue 2, Pages 283-285Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/jid.2010.374
Keywords
-
Categories
Funding
- NIAMS NIH HHS [R01 AR056720] Funding Source: Medline
Ask authors/readers for more resources
One of the most frustrating aspects of treating psoriasis is the tendency of psoriatic skin lesions to recur after therapy has been discontinued. Not only do lesions recur, but they often recur in the same anatomical locations, expanding to the size they were before therapy. This engenders feelings of frustration and futility in both patients and the dermatologists who care for them. In this issue, Suarez-Farinas and colleagues identified a gene set-the residual disease genomic profile-of psoriasis, suggesting the presence of both immunologic and structural abnormalities within healed psoriatic lesions. By understanding this invisible lesion, we may be one step closer to curing psoriasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available